Tuder RM - Search Results

1

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.

Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB; National Heart, Lung and Blood Institute/Office of Rare Diseases. Newman JH, et al. Among authors: tuder rm. Circulation. 2004 Jun 22;109(24):2947-52. doi: 10.1161/01.CIR.0000132476.87231.6F. Circulation. 2004. PMID: 15210611 No abstract available.

2

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Tuder RM, Groves B, Badesch DB, Voelkel NF. Tuder RM, et al. Am J Pathol. 1994 Feb;144(2):275-85. Am J Pathol. 1994. PMID: 7508683 Free PMC article.

3

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

Tuder RM, Flook BE, Voelkel NF. Tuder RM, et al. J Clin Invest. 1995 Apr;95(4):1798-807. doi: 10.1172/JCI117858. J Clin Invest. 1995. PMID: 7706486 Free PMC article.

4

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

Voelkel NF, Tuder RM, Bridges J, Arend WP. Voelkel NF, et al. Among authors: tuder rm. Am J Respir Cell Mol Biol. 1994 Dec;11(6):664-75. doi: 10.1165/ajrcmb.11.6.7946395. Am J Respir Cell Mol Biol. 1994. PMID: 7946395

5

Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.

Voelkel NF, Tuder R. Voelkel NF, et al. Ann N Y Acad Sci. 1994 May 28;725:104-9. doi: 10.1111/j.1749-6632.1994.tb39794.x. Ann N Y Acad Sci. 1994. PMID: 8030981 No abstract available.

6

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.

Voelkel NF, Tuder RM. Voelkel NF, et al. Among authors: tuder rm. Eur Respir J. 1995 Dec;8(12):2129-38. doi: 10.1183/09031936.95.08122129. Eur Respir J. 1995. PMID: 8666110 Free article. Review.

7

Vascular endothelial growth factor in pulmonary hypertension.

Voelkel NF, Hoeper M, Maloney J, Tuder RM. Voelkel NF, et al. Among authors: tuder rm. Ann N Y Acad Sci. 1996 Oct 31;796:186-93. doi: 10.1111/j.1749-6632.1996.tb32580.x. Ann N Y Acad Sci. 1996. PMID: 8906225

8

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.

Cool CD, Kennedy D, Voelkel NF, Tuder RM. Cool CD, et al. Among authors: tuder rm. Hum Pathol. 1997 Apr;28(4):434-42. doi: 10.1016/s0046-8177(97)90032-0. Hum Pathol. 1997. PMID: 9104943

9

Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Lee SD, et al. Among authors: tuder rm. J Clin Invest. 1998 Mar 1;101(5):927-34. doi: 10.1172/JCI1910. J Clin Invest. 1998. PMID: 9486960 Free PMC article.

10

Pulmonary hypertension and inflammation.

Tuder RM, Voelkel NF. Tuder RM, et al. J Lab Clin Med. 1998 Jul;132(1):16-24. doi: 10.1016/s0022-2143(98)90020-8. J Lab Clin Med. 1998. PMID: 9665367 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters